Table of Content

Executive Summary

1 Product Definition

2 Scope of the Work
2.1 Overview: Report Scope
2.2 Segmentation of the Global Hematology Testing Market
2.3 Assumptions and Limitations
2.4 Key Questions Answered in the Report
2.5 Base Year and Forecast Period

3 Research Methodology
3.1 Overview: Report Methodology

4 Global Hematology Testing Market
4.1 Market Overview
4.2 Introduction to Hematology
4.3 Importance of Hematology Testing
4.4 Market Dynamics
4.5 Global Market Scenario
4.6 Assumptions and Limitations

5 Competitive Landscape
5.1 Overview
5.2 Key Developments and Strategies
5.2.1 Product Launch and Development
5.2.2 Product Approvals and Certifications
5.2.3 Collaborations, Partnerships, and Joint Ventures
5.2.4 Business Expansions and Acquisitions
5.2.5 Others
5.3 Market Share Analysis

6 Industry Insights
6.1 Validation of Hematology Systems
6.2 Regulatory Scenario
6.3 Key Industry Insight
6.3.1 Paradigm Shift toward Putting Hematology Analyzers on Lease instead of Sale

7 Global Hematology Testing Market (by Product)
7.1 Overview
7.2 Instruments and Software
7.2.1 Hematology Analyzer and Software
7.2.2 Image Analyzer and Cell Counter
7.2.3 Flow Cytometer
7.2.4 Others
7.3 Consumables
7.3.1 Hematology Reagents
7.3.2 Flow Cytometry Reagents
7.3.3 Stains, Controls, and Calibrators

8 Global Hematology Testing Market (by End User)
8.1 Overview
8.2 Hospitals
8.3 Clinical Testing Laboratories
8.4 Research Institutes
8.5 Patient Self-Testing
8.6 Others

9 Global Hematology Testing Market (by Region)
9.1 Overview
9.2 North America
9.2.1 Overview
9.2.2 U.S.
9.2.3 Canada
9.3 Europe
9.3.1 Overview
9.3.2 Germany
9.3.3 U.K.
9.3.4 France
9.3.5 Italy
9.3.6 Rest-of-Europe
9.4 Asia-Pacific
9.4.1 Overview
9.4.2 Japan
9.4.3 China
9.4.4 India
9.4.5 Australia
9.4.6 South Korea
9.4.7 Rest-of-Asia-Pacific
9.5 Rest-of-the-World
9.5.1 Overview

10 Company Profiles
10.1 Overview
10.2 Abbott Laboratories
10.2.1 Company Overview
10.2.2 Role of Abbott Laboratories in the Global Hematology Testing Market
10.2.3 Financials
10.2.4 SWOT Analysis
10.3 Agilent Technologies, Inc.
10.3.1 Company Overview
10.3.2 Role of Agilent Technologies, Inc. in the Global Hematology Testing Market
10.3.3 Financials
10.3.4 SWOT Analysis
10.4 Bio-Rad Laboratories, Inc.
10.4.1 Company Overview
10.4.2 Role of Bio-Rad Laboratories, Inc. in the Global Hematology Testing Market
10.4.3 Financials
10.4.4 SWOT Analysis
10.5 Boule Diagnostics AB
10.5.1 Company Overview
10.5.2 Role of Boule Diagnostics AB in the Global Hematology Testing Market
10.5.3 Financials
10.5.4 SWOT Analysis
10.6 Danaher Corporation
10.6.1 Company Overview
10.6.2 Role of Danaher Corporation in the Global Hematology Testing Market
10.6.3 Financials
10.6.4 SWOT Analysis
10.7 Drew Scientific Inc.
10.7.1 Company Overview
10.7.2 Role of Drew Scientific Inc. in the Global Hematology Testing Market
10.7.3 SWOT Analysis
10.8 EKF Diagnostics Holdings plc
10.8.1 Company Overview
10.8.2 Role of EKF Diagnostics Holdings plc in the Global Hematology Testing Market
10.8.3 Financials
10.8.4 SWOT Analysis
10.9 F. Hoffmann-La Roche Ltd
10.9.1 Company Overview
10.9.2 Role of F. Hoffmann-La Roche Ltd in the Global Hematology Testing Market
10.9.3 Financials
10.9.4 SWOT Analysis
10.10 HORIBA, Ltd.
10.10.1 Company Overview
10.10.2 Role of HORIBA, Ltd. in the Global Hematology Testing Market
10.10.3 Financials
10.10.4 SWOT Analysis
10.11 Mindray Medical International Limited
10.11.1 Company Overview
10.11.2 Role of Mindray Medical International Limited in the Global Hematology Testing Market
10.11.3 SWOT Analysis
10.12 Nihon Kohden Corporation
10.12.1 Company Overview
10.12.2 Role of Nihon Kohden Corporation in the Global Hematology Testing Market
10.12.3 Financials
10.12.4 SWOT Analysis
10.13 Siemens Healthineers AG
10.13.1 Company Overview
10.13.2 Role of Siemens Healthineers AG in the Global Hematology Testing Market
10.13.3 Financials
10.13.4 SWOT Analysis
10.14 Sysmex Corporation
10.14.1 Company Overview
10.14.2 Role of Sysmex Corporation in the Global Hematology Testing Market
10.14.3 Financials
10.14.4 SWOT Analysis
10.15 Thermo Fisher Scientific Inc.
10.15.1 Company Overview
10.15.2 Role of Thermo Fisher Scientific Inc. in the Global Hematology Testing Market
10.15.3 Financials
10.15.4 SWOT Analysis
10.16 Transasia Bio-Medicals Ltd.
10.16.1 Company Overview
10.16.2 Role of Transasia Bio-Medicals Ltd. in the Global Hematology Testing Market
10.16.3 SWOT Analysis

List of Tables

Table 1: Global Hematology Testing Market, 2018 and 2029
Table 2: Impact Analysis of Market Drivers
Table 3: Impact Analysis of Market Challenges
Table 4.1: Common Hematology Tests and Uses
Table 6.1: Guidelines Under ISLH
Table 6.2: Regulatory Authorities/Associations/Consortiums of the Global Hematology Testing Market
Table 7.1: Examples of Hematology Analyzers Offered by Key Companies of Hematology Testing Market
Table 7.2: Examples of Hematology Reagents Offered by Key Companies of Hematology Testing Market
Table 7.3: Examples of Stains, Controls, and Calibrators Offered by Key Companies of Hematology Testing Market
Table 9.1: Number of Deaths, Incidence, and Prevalence of Common Hematologic Diseases in the U.S. for the Time Period between 2010 and 2017
Table 9.2: Number of Deaths, Incidence, and Prevalence of Common Hematologic Diseases in the Canada between 2010 and 2017
Table 9.3: Number of Deaths, Incidence, and Prevalence of Common Hematologic Diseases in the Germany for the Time Period between 2010 and 2017
Table 9.4: Number of Deaths, Incidence, and Prevalence of Common Hematologic Diseases in the U.K. for the Time Period between 2010 and 2017
Table 9.5: Number of Deaths, Incidence, and Prevalence of Common Hematologic Diseases in France between 2010 and 2017
Table 9.6: Number of Deaths, Incidence, and Prevalence of Common Hematologic Diseases in Italy for the Time Period between 2010 and 2017
Table 9.7: Number of Deaths, Incidence, and Prevalence of Common Hematologic Diseases in Japan for the Time Period between 2010 and 2017
Table 9.8: Number of Deaths, Incidence, and Prevalence of Common Hematologic Diseases in China for the Time Period between 2010 and 2017
Table 9.9: Number of Deaths, Incidence, and Prevalence of Common Hematologic Diseases in India for the Time Period between 2010 and 2017
Table 9.10: Number of Deaths, Incidence, and Prevalence of Common Hematologic Diseases in Australia for the Time Period between 2010 and 2017
Table 9.11: Number of Deaths, Incidence, and Prevalence of Common Hematologic Diseases in South Korea for the Time Period between 2010 and 2017

 



List of Figures



Figure 1: Global Hematology Testing Market Segmentation, 2018 and 2029
Figure 2: Share of Key Developments and Strategies, January 2016-July 2019
Figure 3: Global Hematology Testing Market Share (by Company), 2018
Figure 4: Global Hematology Testing Market Share (by Product Type), 2018 and 2029
Figure 5: Global Hematology Testing Market Share (by End User), 2018 and 2029
Figure 6: Global Hematology Testing Market Share (by Region), 2018 and 2029
Figure 2.1: Global Hematology Testing Market Segmentation
Figure 3.1: Global Hematology Testing Market Research Methodology
Figure 3.2: Primary Research
Figure 3.3: Secondary Research
Figure 3.4: Data Triangulation
Figure 3.5: Bottom-up Approach (Segment-wise Analysis)
Figure 3.6: Top-Down Approach (Segment-wise Analysis)
Figure 3.7: Assumptions and Limitations
Figure 4.1: Drivers and Challenges of the Global Hematology Testing Market
Figure 4.2: Global Hematology Testing Market, 2018-2029
Figure 5.1: Competitive Landscape (January 2016-September- 2019)
Figure 5.2: Share of Key Developments and Strategies, January 2016-September 2019
Figure 5.3: Product Launches and Developments (by Company), January 2016 and September 2019
Figure 5.4: Product Approvals and Certifications (by Company), January 2016 and September 2019
Figure 5.5: Collaborations, Partnerships, and Joint Ventures (by Company), January 2016 and September 2019
Figure 5.6: Business Expansions (by Company), January 2016 and September 2019
Figure 5.7: Market Share Analysis of Global Hematology Testing Market, 2017 and 2018
Figure 7.1: Global Hematology Testing Market Segmentation (by Product Type)
Figure 7.2: Global Hematology Testing Market (by Product), 2018-2029
Figure 7.3: Global Hematology Testing Market (by Instrument and Software), 2018-2029
Figure 7.4: Global Hematology Testing Market (Hematology Analyzer and Software), 2018-2029
Figure 7.5: Global Hematology Testing Market (Image Analyzer and Cell Counter), 2018-2029
Figure 7.6: Global Hematology Testing Market (Flow Cytometer), 2018-2029
Figure 7.7: Global Hematology Testing Market (Others), 2018-2029
Figure 7.8: Global Hematology Testing Market (by Consumable), 2018-2029
Figure 7.9: Global Hematology Testing Market (Hematology Reagents), 2018-2029
Figure 7.10: Global Hematology Testing Market (Flow Cytometry Reagents), 2018-2029
Figure 7.11: Global Hematology Testing Market (Stains, Controls, and Calibrators Reagents), 2018-2029
Figure 8.1: Global Hematology Testing Market Segmentation (by End User)
Figure 8.2: Global Hematology Testing Market (by End User), 2018-2029
Figure 8.3: Global Hematology Testing Market (Hospitals), 2018-2029
Figure 8.4: Global Hematology Testing Market (Clinical Testing Laboratories), 2018-2029
Figure 8.4: Global Hematology Testing Market (Research Institutes), 2018-2029
Figure 8.5: Global Hematology Testing Market (Patient Self-Testing), 2018-2029
Figure 8.6: Global Hematology Testing Market (Others), 2018-2029
Figure 9.1: Global Hematology Testing Market (by Region), 2018-2029
Figure 9.2: North America: Hematology Testing Market, 2018-2029
Figure 9.3: North America: Market Dynamics
Figure 9.4: North America: Hematology Testing Market (by Country), 2018-2029
Figure 9.5: U.S.: Hematology Testing Market, 2018-2029
Figure 9.6: Canada: Hematology Testing Market, 2018-2029
Figure 9.7: Europe: Hematology Testing Market, 2018-2029
Figure 9.8: Europe: Market Dynamics
Figure 9.9: Europe: Hematology Testing Market (by Country), 2018-2029
Figure 9.10: Germany: Hematology Testing Market, 2018-2029
Figure 9.11: U.K.: Hematology Testing Market, 2018-2029
Figure 9.12: France: Hematology Testing Market, 2018-2029
Figure 9.13: Italy: Hematology Testing Market, 2018-2029
Figure 9.14: Rest-of-Europe: Hematology Testing Market, 2018-2029
Figure 9.15: Asia-Pacific: Hematology Testing Market, 2018-2029
Figure 9.16: Asia-Pacific: Market Dynamics
Figure 9.17: Asia-Pacific: Hematology Testing Market (by Country), 2018-2029
Figure 9.18: Japan: Hematology Testing Market, 2018-2029
Figure 9.19: China: Hematology Testing Market, 2018-2029
Figure 9.20: India: Hematology Testing Market, 2018-2029
Figure 9.21: Australia: Hematology Testing Market, 2018-2029
Figure 9.22: South Korea: Hematology Testing Market, 2018-2029
Figure 9.23: Rest-of-Asia-Pacific: Hematology Testing Market, 2018-2029
Figure 9.24: Rest-of-the-World: Hematology Testing Market, 2018-2029
Figure 9.25: Rest-of-the-World: Market Dynamics
Figure 10.1: Shares of Key Company Profiles
Figure 10.2: Abbott Laboratories: Product Portfolio for Global Hematology Testing Market
Figure 10.3: Abbott Laboratories: Overall Financials, 2016-2018
Figure 10.4: Abbott Laboratories: Revenue (by Business Segment), 2016-2018
Figure 10.5: Abbott Laboratories: Revenue (by Region), 2016-2018
Figure 10.6: Abbott Laboratories: R&D Expenditure (2016-2018)
Figure 10.7: Abbott Laboratories: SWOT Analysis
Figure 10.8: Agilent Technologies, Inc.: Product Portfolio for Global Hematology Testing Market
Figure 10.9: Agilent Technologies, Inc.: Overall Financials, 2016-2018
Figure 10.10: Agilent Technologies, Inc.: Revenue (by Business Segment), 2016-2018
Figure 10.11: Agilent Technologies, Inc.: (by Region), 2016-2018
Figure 10.12: Agilent Technologies, Inc.: R&D Expenditure (2016-2018)
Figure 10.13: Agilent Technologies, Inc.: SWOT Analysis
Figure 10.14: Bio-Rad Laboratories, Inc.: Product Portfolio for Global Hematology Testing Market
Figure 10.15: Bio-Rad Laboratories, Inc.: Overall Financials, 2016-2018
Figure 10.16: Bio-Rad Laboratories, Inc.: Revenue (by Business Segment), 2016-2018
Figure 10.17: Bio-Rad Laboratories, Inc.: Revenue (by Region), 2016-2018
Figure 10.18: Bio-Rad Laboratories, Inc.: R&D Expenditure (2016-2018)
Figure 10.19: Bio-Rad Laboratories, Inc.: SWOT Analysis
Figure 10.20: Boule Diagnostics AB: Product Portfolio for Global Hematology Testing Market
Figure 10.21: Boule Diagnostics AB: Overall Financials, 2016-2018
Figure 10.22: Boule Diagnostics AB: Revenue (by Business Segment), 2016-2018
Figure 10.23: Boule Diagnostics AB: Revenue (by Region), 2016-2018
Figure 10.24: Boule Diagnostics AB: R&D Expenditure (2016-2018)
Figure 10.25: Boule Diagnostics AB: SWOT Analysis
Figure 10.26: Danaher Corporation: Product Portfolio for Global Hematology Testing Market
Figure 10.27: Danaher Corporation: Overall Financials, 2016-2018
Figure 10.28: Danaher Corporation: Revenue (by Business Segment), 2016-2018
Figure 10.29: Danaher Corporation: Revenue (by Region), 2016-2018
Figure 10.30: Danaher Corporation: R&D Expenditure (2016-2018)
Figure 10.31: Danaher Corporation: SWOT Analysis
Figure 10.32: Drew Scientific Inc.: Product Portfolio for Global Hematology Testing Market
Figure 10.33: Drew Scientific Inc.: SWOT Analysis
Figure 10.34: EKF Diagnostics Holdings plc: Product Portfolio for Global Hematology Testing Market
Figure 10.35: EKF Diagnostics Holdings plc: Overall Financials, 2016-2018
Figure 10.36: EKF Diagnostics Holdings plc: Revenue (by Business Segment), 2016-2018
Figure 10.37: EKF Diagnostics Holdings plc: (by Region), 2016-2018
Figure 10.38: EKF Diagnostics Holdings plc: R&D Expenditure (2016-2018)
Figure 10.39: EKF Diagnostics Holdings plc: SWOT Analysis
Figure 10.40: F. Hoffmann-La Roche Ltd: Product Portfolio for Global Hematology Testing Market
Figure 10.41: F. Hoffmann-La Roche Ltd: Overall Financials, 2016-2018
Figure 10.42: F. Hoffmann-La Roche Ltd: Revenue (by Business Segment), 2016-2018
Figure 10.43: F. Hoffmann-La Roche Ltd: (Revenue by Diagnostics Segment), 2016-2018
Figure 10.44: F. Hoffmann-La Roche Ltd: Revenue (by Region), 2016-2018
Figure 10.45: F. Hoffmann-La Roche Ltd: R&D Expenditure (2016-2018)
Figure 10.46: F. Hoffmann-La Roche Ltd: SWOT Analysis
Figure 10.47: HORIBA, Ltd.: Product Portfolio for Global Hematology Testing Market
Figure 10.48: HORIBA, Ltd.: Overall Financials, 2016-2018
Figure 10.49: HORIBA, Ltd.: Revenue (by Business Segment), 2016-2018
Figure 10.50: HORIBA, Ltd.: Medical-Diagnostic Instruments & Systems Revenue (by Region), 2016-2018
Figure 10.51: HORIBA, Ltd.: R&D Expenditure (2016-2018)
Figure 10.52: HORIBA, Ltd.: SWOT Analysis
Figure 10.53: Mindray Medical International Limited: Product Portfolio for Global Hematology Testing Market
Figure 10.54: Mindray Medical International Limited: SWOT Analysis
Figure 10.55: Nihon Kohden Corporation: Product Portfolio for Global Hematology Testing Market
Figure 10.56: Nihon Kohden Corporation: Overall Financials, 2016-2018
Figure 10.57: Nihon Kohden Corporation: Revenue (by Business Segment), 2016-2018
Figure 10.58: Nihon Kohden Corporation: Revenue (by Region), 2016-2018
Figure 10.59: Nihon Kohden Corporation: R&D Expenditure (2016-2018)
Figure 10.60: Nihon Kohden Corporation: SWOT Analysis
Figure 10.61: Siemens Healthineers AG: Product Portfolio for Global Hematology Testing Market
Figure 10.62: Siemens Healthineers AG: Overall Financials, 2016-2018
Figure 10.63: Siemens Healthineers AG: Revenue (by Business Segment), 2016-2018
Figure 10.64: Siemens Healthineers AG: Revenue (by Region), 2016-2018
Figure 10.65: Siemens Healthineers AG: R&D Expenditure (2016-2018)
Figure 10.66: Siemens Healthineers AG: SWOT Analysis
Figure 10.67: Sysmex Corporation: Product Portfolio for Global Hematology Testing Market
Figure 10.68: Sysmex Corporation: Overall Financials, 2016-2018
Figure 10.69: Sysmex Corporation: Revenue (by Business Segment), 2016-2018
Figure 10.70: Sysmex Corporation: Revenue (by Region), 2016-2018
Figure 10.71: Sysmex Corporation: R&D Expenditure (2016-2018)
Figure 10.72: Sysmex Corporation: SWOT Analysis
Figure 10.73: Thermo Fisher Scientific Inc.: Product Portfolio for Global Hematology Testing Market
Figure 10.74: Thermo Fisher Scientific Inc.: Overall Financials, 2016-2018
Figure 10.75: Thermo Fisher Scientific Inc.: Revenue (by Business Segment), 2016-2018
Figure 10.76: Thermo Fisher Scientific Inc.: Revenue (by Region), 2016-2018
Figure 10.77: Thermo Fisher Scientific Inc.: R&D Expenditure (2016-2018)
Figure 10.78: Thermo Fisher Scientific Inc.: SWOT Analysis
Figure 10.79: Transasia Bio-Medicals Ltd.: Product Portfolio for Global Hematology Testing Market
Figure 10.80: Transasia Bio-Medicals Ltd.: SWOT Analysis